TGF-beta receptor type-2, Cell Signalling Technology, 41896S

Our team has carried out deep research in the published scientific literature to identify papers and reports using antibodies directed against human TGFBR2 and followed up by extraction and evaluation of the available data to assess its performance according to pAbmAbs rating criteria.

YCharOS is here conducting a large head-to-head study comparing 12 commercial research antibodies against human TGFBR2.

The collection of antibodies was tested using A549 WT and TGFBR2 KO cells in the applications WB (WT and KO cell lysates/30 µg protein) and flow cytometry (KO and WT cells: intracellular and cell surface) according to YCharOS standard protocols (see reference).

In WB (1:1000 ab dilution) 41896S did not detect a band. Flow cytometry using 41896S (1:340 ab dilution) showed overlapping fluorescence intensity distributions for WT and KO cells, with no visible shift between the two populations.